What is the recommended starting dose of Vyvanse (lisdexamfetamine) for a 24-year-old female with Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Vyvanse for a 24-Year-Old Female with ADHD

The recommended starting dose of Vyvanse (lisdexamfetamine) for a 24-year-old female with ADHD is 30 mg once daily in the morning, with dosage adjustments in increments of 10-20 mg at approximately weekly intervals up to a maximum of 70 mg daily as needed. 1

Dosing Protocol

Initial Dosing

  • Start with 30 mg once daily in the morning 2, 1
  • Take with or without food 1
  • Avoid afternoon doses to prevent insomnia 1

Dose Titration

  • Adjust dose in increments of 10 mg or 20 mg at approximately weekly intervals 1
  • Schedule follow-up within 2-4 weeks after medication adjustment to assess response and side effects 2
  • Target dose range: 30-70 mg once daily 1
  • Maximum recommended dose: 70 mg once daily 1

Administration Options

Vyvanse can be taken in several ways:

  • Swallow capsule whole
  • Open capsule and mix entire contents with yogurt, water, or orange juice
  • Consume mixture immediately after mixing (do not store) 1

Monitoring Parameters

Initial Assessment

  • Assess for cardiac disease (careful history, family history of sudden death or ventricular arrhythmia, physical exam) 1
  • Evaluate for history of tics or Tourette's syndrome 1
  • Check baseline vital signs and weight 2

Follow-up Monitoring

  • Monitor for effectiveness in reducing ADHD symptoms
  • Assess for common side effects:
    • Decreased appetite (reported in 49.4% of patients) 3
    • Insomnia (reported in 13.1% of patients) 3
    • Headache (reported in 5.7% of patients) 3
    • Weight decrease (reported in 18.2% of patients) 3
  • Monitor vital signs for changes in:
    • Blood pressure (mean increases of 3.4 mmHg systolic and 3.2 mmHg diastolic) 3
    • Heart rate (mean increase of 7.0 bpm) 3

Clinical Considerations

Efficacy

  • Lisdexamfetamine has demonstrated efficacy for up to 14 hours post-dose in adults 4
  • Studies show significant improvements in ADHD rating scales, Clinical Global Improvement scores, and executive function assessments 4
  • Response may begin as early as the first week of treatment 5

Contraindications

  • Known hypersensitivity to amphetamine products
  • Concurrent use of MAOIs or within 14 days of stopping MAOIs
  • Glaucoma, symptomatic cardiovascular disease, hyperthyroidism, hypertension 1

Special Populations

  • In patients with severe renal impairment (GFR 15 to <30 mL/min/1.73 m²), maximum dose should not exceed 50 mg once daily
  • In end-stage renal disease (GFR <15 mL/min/1.73 m²), maximum dose is 30 mg once daily 1

Potential Pitfalls and Caveats

  • Avoid using multiple stimulant formulations concurrently 2
  • Be aware of high potential for abuse and misuse; educate patient about proper storage and disposal 1
  • Acidifying agents (e.g., ascorbic acid) decrease blood levels, while alkalinizing agents (e.g., sodium bicarbonate) increase blood levels; adjust dosage accordingly 1
  • Morning dosing is recommended to avoid insomnia 1
  • Monitor for psychiatric symptoms or emergence of tics 2

Lisdexamfetamine is a prodrug stimulant that remains pharmacologically inactive until enzymatically converted to d-amphetamine, providing consistent symptom control throughout the day 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.